期刊文献+

单次胺碘酮预防男性急诊体外循环冠状动脉旁路移植术后心房颤动的疗效评价 被引量:4

The effects of intraoperative a single dose of amiodarone on atrial fibrillation after emergency on-pump coronary artery bypass grafting in mail patients
下载PDF
导出
摘要 目的:探讨单次应用胺碘酮对男性患者行急诊体外循环冠状动脉旁路移植术(ONCABG)后新发心房颤动预防的疗效.方法:50例美国麻醉医师协会(ASA)患者全身状况分级III-IV级急诊行ONCABG的男性患者,均伴有高血压和2型糖尿病病史。随机分为试验组(Y组,n=25)和对照组(C组,n=25)。Y组和C组分别在升主动脉开放前经中心静脉注入0.9%氯化钠液20mL和胺碘酮注射液20mL(3mg/kg)。结果:Y组和C组的术后心房颤动发生率(28%vs.24%),胺碘酮转复率(100%vs.100%),差异无统计学意义,但是多元线性回归显示体外循环时间和术后发生心房颤动会影响患者ICU入住时间(P<0.05)。结论:单次静脉预防性应用胺碘酮并不能降低男性患者急诊ONCABG术后心房颤动的发生率;长时间体外循环和术后新发心房颤动是延长患者ICU入住时间的独立危险因素。 Objective:To investigate the effects of intraoperative a single dose of amiodarone on Atrial Fibrillation after emergency on-pump coronary artery bypass grafting (ONCABG) in mail patients. Methods: 50 ASA Ⅲ-Ⅳ(mails), with hypertension and type 2 diabetes, aged 49-73 undergoing emergency ONCABG were randomly divided into two groups: edaravone group (group Y, n = 25 )received amiodarone 3mg/kg(20mL) Via central venous before opening the ascending aorta, and control group( group C, n = 25 ) did not receive amio darone instead of normal saline(20mL). Results: the incidence of atrial fibrillation(28% vs. 24% ) ,cardiover sion of atrial fibrillation rate ( 100% vs. 100% ), there were no significant difference in the two groups. But, cardiopulmonary bypass(CPB) time and postoperative atrial fibrillation affects ICU days of patients ( P 〈 0. 05 ) by multiple linear regression analysis. Conclusion : A single dose of amiodarone can not reduce incidence of atrial fibrillation after emergency ONCABG in mail patients. Longer CPB time and postoperative atrial fibrillation are risk factors for longer ICU days.
出处 《心肺血管病杂志》 CAS 2014年第3期398-401,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 体外循环 冠状动脉旁路移植术 心房颤动 胺碘酮 Cardiopulmonary bypass Coronary artery bypass grafting Atrial fibrillation Amiodarone
  • 相关文献

参考文献15

  • 1McKeown PP. American college of chest physicians, introduc- tion : American college of chest physicians guidelines for the pre- vention and management of postoperative atrial fibrillation after cardiac surgery. Chest, 2005,128 ( 2 Suppl) : 6 S-8 S.
  • 2Zaman AG, Archbold RA, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation, 2000,101 : 1403-1408.
  • 3Aksnes TA, Schmieder RE, Kjeldsen SE, et al. Impact of new- onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol, 2008, 101:634-638.
  • 4Huxley RR, Alonso A,Lopez FL, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the atherosclerosis risk in communities study. Heart, 2012,98:133-138.
  • 5Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery : predictors, outcomes, and resource utilization. MuhiCenter Study of Perioperative Ischemia Research Group. JAMA, 1996,276:300-306.
  • 6Hashemzadeh K, Dehdilani M, Dehdilani M. Does off-pump cor- onary artery bypass reduce the prevalence of atrial fibrillation? JCardiovasc Thorac Res, 2013,5:45-49.
  • 7DiDomenico RJ, Massad MG. Pharmacologic strategies for pre- vention of atrial fibrillation after open heart surgery. Ann Thorac Surg, 2005,79:728-740.
  • 8Dorge H, Schoendube FA, Schoberer M, et al. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg,2000,69 : 1358-1362.
  • 9Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery, a report of the American college of cardiology foundation/American heart associ- ation task force on practice guidelines. Developed in collaboration with the American association for thoracic surgery, society of car- diovascular anesthesiologists, and society of thoracic surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
  • 10Chauhan VS, Woodend KA, Tang AS. Lower incidence of atrial fi- brillation after minimally invasive direct coronary arterybypass surgery than bypass surgery. Circulation, 1997,96 ( suppl 1 ) :263.

二级参考文献9

  • 1[1]Cohn WE, Sirois CA, Johnson RG. Atrial fibrillation after minimally invasive coronary artery bypass grafting:a retrospective, matched study. J Thorac Cardiovasc Surg, 1999, 117(2):298-301.
  • 2[2]Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery-predictors, outcomes, and resource utilization. JAMA, 1996, 276(4):300-306.
  • 3[3]Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg, 1993, 56(3):539-549.
  • 4[4]Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J, 1972, 34(5):520-525.
  • 5[5]Nystrom U, Shandling AH, Edvardsson N, et al. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg, 1993, 41(1):34-37.
  • 6[6]Matangi MF, Neutze JM, Graham KJ, et al. Arrhythmia prophylaxis after aorta-coronary bypass: the effect of minidose propranolol. J Thorac Cardiovasc Surg, 1985, 89(3):439-443.
  • 7[7]Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med, 1998, 339(8):489-497.
  • 8[8]Nurozler F, Tokgozoglu L, Pasaoglu I, et al. Atrial fibrillation after coronary artery bypass surgery:predictors and the role of MgSO4 replacement. J Card Surg, 1996, 11(6):421-427.
  • 9[9]Jensen BM, Alstrup P, Klitgard NA, et al. Postoperative arrhythmias and myocardial electrolytes in patients undergoing coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg, 1996, 30(3):133-140.

共引文献30

同被引文献70

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部